1. Targeting CXCR4 and EDN1 for the treatment of recurrent miscarriage using stearic acid from traditional Chinese medicine.
- Author
-
Fang Liu, Dong-Mei Shi, Wen-Ye Ma, Da-Wei Tang, Gang Bai, and Xin-You Yu
- Subjects
- *
PREPROENDOTHELIN , *GENE expression , *STEARIC acid , *RNA analysis , *CHINESE medicine , *CXCR4 receptors - Abstract
Background: Recurrent miscarriage (RM) affects an estimated 1-3% of couples attempting to conceive, and its molecular components stay ineffectively caught on. This study aims to explore potential therapeutic targets for RM by examining gene expression patterns and biological pathways in both mouse and human RM models. Meanwhile, explore relevant traditional Chinese medicine (TCM) components targeting potential therapeutic targets. Methods: We utilized the GSE211251 mouse and the GSE26787 human datasets, employing gene set enrichment analysis and gene metaphysics analysis to examine differentially expressed genes and enriched pathways. Single-cell RNA analysis uncovered cellular heterogeneity and arranged pharmacology-mapped potential drug-target intelligence. We employed molecular docking strategies to assess the affinity of TCM components for key proteins. Results: In the mouse model, genes such as Ly6f1 and Gpr26 were upregulated, while Stc5a and Galca exhibited downregulation. Gene set enrichment analysis identified key pathways, including the tumor necrosis factor-mediated signaling pathway. In human samples, Gene Ontology analysis highlighted processes such as apoptosis and cell adhesion. Single-cell RNA analysis revealed distinct cellular populations between normal and RM samples. Systems pharmacology identified C-X-C motif chemokine receptor 4 (CXCR4) and endothelin 1 (EDN1) as potential key targets, and molecular docking confirmed that stearic acid from TCM appears to regulate these proteins. Conclusion: This study presents a comprehensive analysis of the genetic and cellular underpinnings of RM, identifying CXCR4 and EDN1 as promising therapeutic targets. Stearic acid from TCM could provide targeted treatment by modulating these key proteins, paving the way for new RM treatment strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF